Research and Markets: United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2009
* Reuters is not responsible for the content in this press release.
DUBLIN, Ireland--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/24ed01/united_arab_emirat) has announced the addition of the "United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2009" report to their offering. BMI's United Arab Emirates Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the United Arab Emirates's pharmaceuticals and healthcare industry. For the Q109 update of UAE's Pharmaceutical and Healthcare report, BMI has extended our forecast for the pharmaceutical sector through to 2013. We expect drug market spending to increase from US$850mn in 2008 to US$1.41bn in 2013, representing y-o-y growth of 10%. A main driver for increased spending comes in the form of increasing burden of lifestyle related diseases such as diabetes, cardiovascular disease and certain cancers. Health spending per capita is projected to rise from US$1,525 in 2008 to US$2,310 by 2013. The rise in healthcare investments, including speciality hospitals and the DuBiotech science park will encourage multinational activity into the country, with a view to extensively developing the R&D sector. Key Topics Covered: * Executive Summary * Pharmaceutical Business Environment Ratings * Market Summary * Regulatory Environment * Industry Trends And Developments * Industry Forecast Scenario * Competitive Landscape * Company Profiles * Country Snapshot: UAE Demographic Data * BMI Forecast Modelling Companies Mentioned: * GlaxoSmithKline * Pfizer * Novartis * Johnson & Johnson (J&J) * Sanofi-Aventis * Abbott Laboratories * Merck & Co * Gulf Pharmaceutical Industries (Julphar) * Globalpharma * Modern Pharmaceutical Company (MPC) * NeoPharma For more information visit http://www.researchandmarkets.com/research/24ed01/united_arab_emirat Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters